RESCORAX 150 SE
ZOVIRALIS 525 WDG
Resistance Mitigation Potential: Cymoxanil component helps buffer QoI resistance when used correctly.
FLUCLEAR 500 SC
Resistance-Breaker: Multi-site-like behaviour, reducing risk of resistance build-up even under repeated use.
CUPRAVA 700 SC
Low Resistance Risk: Multi-site copper mode of action prevents pathogen adaptation.
DUOSHIELD 450 SC
Dual active ingredients reduce resistance risk and prolong efficacy.
KOPRINIL 440 WP
Synergy: Cymoxanil addresses active oomycete infections, while copper prevents new infections and suppresses bacterial growth.
CYMORA 720 WP
The combination of Mancozeb and Cymoxanil delivers dual-phase protection.
CUPROMAX 770 WP
CUPROMAX 770 WP operates through a multi-site, non-specific biochemical disruption mechanism… copper interferes with multiple independent biochemical sites, pathogens are unable to develop effective metabolic bypass mechanisms.